A route for investigating psoriasis: from the perspective of the pathological mechanisms and therapeutic strategies of cancer

X Wu, Y Ma, L Wang, X Qin - International Journal of Molecular Sciences, 2023 - mdpi.com
Psoriasis is an incurable skin disease that develops in about two-thirds of patients before the
age of 40 and requires lifelong treatment; its pathological mechanisms have not been fully …

CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity–a narrative review

D Pavlovic, D Niciforovic, D Papic… - Therapeutic …, 2023 - journals.sagepub.com
Breast cancer is characterized by the uncontrolled proliferation of breast cells, with a high
incidence reported in 2020 to have affected over 2 million women. In recent years, the …

Tumor biomarkers for diagnosis, prognosis and targeted therapy

Y Zhou, L Tao, J Qiu, J Xu, X Yang, Y Zhang… - … and Targeted Therapy, 2024 - nature.com
Tumor biomarkers, the substances which are produced by tumors or the body's responses to
tumors during tumorigenesis and progression, have been demonstrated to possess critical …

Targeted protein degradation: advances in drug discovery and clinical practice

G Zhong, X Chang, W Xie, X Zhou - Signal Transduction and Targeted …, 2024 - nature.com
Targeted protein degradation (TPD) represents a revolutionary therapeutic strategy in
disease management, providing a stark contrast to traditional therapeutic approaches like …

Targeting Breast Cancer: The Familiar, the Emerging, and the Uncharted Territories

H Montazeri Aliabadi, A Manda, R Sidgal, C Chung - Biomolecules, 2023 - mdpi.com
Breast cancer became the most diagnosed cancer in the world in 2020. Chemotherapy is
still the leading clinical strategy in breast cancer treatment, followed by hormone therapy …

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review

ZQ Liu, Q Zhang, YL Liu, XQ Yu, RH Chui… - Bioorganic & Medicinal …, 2024 - Elsevier
Pyridazine, as a privileged scaffold, has been extensively utilized in drug development due
to its multiple biological activities. Especially around its distinctive anticancer property, a …

Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy

KKW To, WC Cho - Pharmaceutics, 2023 - mdpi.com
Immune checkpoint inhibitors (ICI) have achieved unprecedented clinical success in cancer
treatment. However, drug resistance to ICI therapy is a major hurdle that prevents cancer …

Regulation of the cell cycle by ncRNAs affects the efficiency of CDK4/6 inhibition

Q Hu, T Huang - International Journal of Molecular Sciences, 2023 - mdpi.com
Cyclin-dependent kinases (CDKs) regulate cell division at multiple levels. Aberrant
proliferation induced by abnormal cell cycle is a hallmark of cancer. Over the past few …

[HTML][HTML] Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets

M Sun, Y Ji, G Zhang, Y Li, F Dong, T Wu - Biomedicine & Pharmacotherapy, 2024 - Elsevier
The E2F transcription factor family, whose members are encoded by the E2F1-E2F8 genes,
plays pivotal roles in the cell cycle, apoptosis, metabolism, stemness, metastasis, aging …

Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets

S Liu, W Dai, B Jin, F Jiang, H Huang, W Hou, J Lan… - Molecular Cancer, 2024 - Springer
Metastasis remains the principal cause of cancer-related lethality despite advancements in
cancer treatment. Dysfunctional epigenetic alterations are crucial in the metastatic cascade …